Condition: Obesity or Overweight · Type 2 Diabetes Mellitus · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants with obesity or overweight and Type 2 diabetes mellitus (T2DM).
This description comes directly from the study's public registry record.
Reference Study ID Number: WC45726 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Lakeview Clinical Research | Guntersville, Alabama, United States | Recruiting |
| Arizona Clinical Trials | Tucson, Arizona, United States | Recruiting |
| Orange County Research Center | Lake Forest, California, United States | Recruiting |
| Ark Clinical Research | Long Beach, California, United States | Recruiting |
| Catalina Research Institute, LLC | Montclair, California, United States | Recruiting |
| Infinity Clinical Research | Norco, California, United States | Recruiting |
| Prospective Research Innovations Inc. | Rancho Cucamonga, California, United States | Recruiting |
| Encompass Clinical Research | Spring Valley, California, United States | Recruiting |
| Emerson Clinical Research Institute | Washington D.C., District of Columbia, United States | Recruiting |
| Tampa Bay Medical Research, Inc. | Clearwater, Florida, United States | Recruiting |
| Center for Diabetes, Obesity and Metabolism Inc | Pembroke Pines, Florida, United States | Recruiting |
| Progressive Medical Research | Port Orange, Florida, United States | Recruiting |
+ 151 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07351058